This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
united states | 3007 |
public health | 995 |
health care | 719 |
infectious diseases | 496 |
lyme disease | 354 |
clinical signs | 341 |
design method | 318 |
member states | 292 |
infection control | 275 |
infectious disease | 269 |
new york | 234 |
respiratory syndrome | 232 |
hiv aids | 225 |
acute respiratory | 220 |
united kingdom | 215 |
disease control | 211 |
may also | 195 |
risk factors | 194 |
severe acute | 185 |
bone marrow | 176 |
world health | 175 |
developing countries | 162 |
pediatric patients | 160 |
may occur | 158 |
west nile | 158 |
health organization | 152 |
states background | 148 |
nile virus | 147 |
human rights | 144 |
incubation period | 137 |
intensive care | 135 |
clinical trials | 134 |
north america | 124 |
united nations | 123 |
mg kg | 123 |
escherichia coli | 122 |
climate change | 122 |
mental health | 121 |
respiratory tract | 120 |
staphylococcus aureus | 120 |
per year | 118 |
biological weapons | 118 |
cord uid | 116 |
increased risk | 116 |
high risk | 116 |
doc id | 116 |
national health | 115 |
nervous system | 114 |
confirmed cases | 113 |
health insurance | 109 |
advisory committee | 108 |
steering committee | 107 |
feral cats | 106 |
emerging infectious | 106 |
world war | 106 |
sickle cell | 105 |
infectious agents | 105 |
pregnant women | 104 |
critical care | 102 |
differential diagnosis | 102 |
avian influenza | 102 |
care unit | 101 |
virus infection | 101 |
th century | 99 |
young children | 97 |
medical care | 96 |
lymph nodes | 95 |
care settings | 94 |
years old | 94 |
central nervous | 90 |
weight loss | 88 |
liver oil | 88 |
hiv infection | 88 |
health systems | 87 |
european union | 86 |
stem cell | 85 |
us fda | 84 |
cod liver | 84 |
control measures | 82 |
online labour | 82 |
million people | 81 |
median age | 80 |
cell disease | 80 |
social distancing | 80 |
working group | 79 |
influenza pandemic | 79 |
infected animals | 78 |
international order | 78 |
gastrointestinal tract | 78 |
developed countries | 78 |
blood cell | 78 |
antibiotic therapy | 77 |
eu member | 77 |
affective polarization | 77 |
hemorrhagic fever | 76 |
herd immunity | 75 |
red blood | 75 |
may lead | 75 |
affected animals | 75 |
risk factor | 75 |
may cause | 75 |
homeland security | 74 |
may result | 74 |
hong kong | 72 |
older adults | 71 |
health system | 71 |
health services | 71 |
endemic areas | 70 |
york city | 70 |
may include | 70 |
cell lines | 70 |
natural disasters | 70 |
systematic review | 69 |
age years | 69 |
influenza virus | 69 |
even though | 69 |
healthcare workers | 68 |
drug administration | 68 |
medicinal products | 68 |
antimicrobial resistance | 67 |
income countries | 67 |
per cent | 67 |
many countries | 67 |
care facilities | 67 |
patient care | 66 |
chart review | 66 |
clinical disease | 66 |
resistant staphylococcus | 66 |
necropsy findings | 65 |
immunization practices | 65 |
young adults | 65 |
new cases | 65 |
among children | 65 |
risk assessment | 65 |
zoonotic diseases | 64 |
abdominal pain | 63 |
south america | 63 |
antimicrobial therapy | 63 |
war ii | 62 |
primary care | 62 |
world trade | 62 |
pediatric oncology | 62 |
influenza viruses | 62 |
one patient | 61 |
saharan africa | 61 |
american dream | 61 |
pandemic influenza | 61 |
human services | 60 |
attenuated live | 60 |
borne diseases | 60 |
hand hygiene | 60 |
zoonotic disease | 60 |
immune response | 60 |
mortality rates | 60 |
soviet union | 60 |
health service | 59 |
states department | 59 |
yellow fever | 59 |
human health | 59 |
blood transfusion | 59 |
immunodeficiency virus | 59 |
money laundering | 59 |
retrospective chart | 58 |
respiratory infections | 57 |
animals may | 57 |
within hours | 57 |
respiratory disease | 57 |
animal health | 57 |
traumatic stress | 56 |
direct contact | 56 |
mortality rate | 56 |
middle east | 56 |
standard precautions | 56 |
see chapter | 56 |
air pollution | 56 |
chemical weapons | 56 |
social protection | 56 |
biological agents | 56 |
care workers | 56 |
respiratory distress | 56 |
new zealand | 55 |
human immunodeficiency | 55 |
least one | 55 |
case fatality | 55 |
disease may | 55 |
upper respiratory | 55 |
care facility | 54 |
statistically significant | 54 |
care system | 54 |
inhalational anthrax | 54 |
latin america | 54 |
cohort study | 54 |
task force | 53 |
supportive care | 53 |
less likely | 53 |
life cycle | 53 |
lymphoblastic leukemia | 53 |
past years | 53 |
domestic animals | 53 |
coronavirus disease | 52 |
acute lymphoblastic | 52 |
see table | 52 |
blood cultures | 52 |
mucous membranes | 52 |
blood donors | 52 |
member state | 52 |
large numbers | 52 |
heart disease | 52 |
ebola virus | 52 |
global health | 51 |
will continue | 51 |
salmonella dublin | 51 |
family members | 51 |
control practices | 51 |
within days | 51 |
respiratory failure | 51 |
south africa | 51 |
respiratory syncytial | 51 |
adverse events | 51 |
federal government | 51 |
patients received | 51 |
body fluids | 50 |
critically ill | 50 |
side effects | 50 |
may develop | 50 |
st century | 50 |
mouth disease | 50 |
protective equipment | 49 |
virus vaccine | 49 |
prospective study | 49 |
leading cause | 49 |
borrelia burgdorferi | 49 |
communicable diseases | 49 |
lung function | 49 |
will also | 49 |
spinal cord | 49 |
personal protective | 48 |
mean age | 48 |
vaccine development | 48 |
syncytial virus | 48 |
north american | 48 |
clostridium difficile | 48 |
high levels | 48 |
chain reaction | 48 |
decision making | 48 |
adopted children | 47 |
medical center | 47 |
per capita | 47 |
los angeles | 47 |
biological weapon | 47 |
home care | 47 |
campylobacter jejuni | 47 |
professional development | 47 |
porcine reproductive | 47 |
european commission | 46 |
emerging infections | 46 |
tailed deer | 46 |
surveillance system | 46 |
polymerase chain | 46 |
novel coronavirus | 46 |
dog food | 46 |
childhood cancer | 46 |
care providers | 46 |
childhood asthma | 46 |
clinical trial | 46 |
rotavirus infection | 46 |
large number | 46 |
infection may | 45 |
recent years | 45 |
disease caused | 45 |
reported cases | 45 |
determine whether | 45 |
infectious agent | 45 |
law enforcement | 45 |
term care | 45 |
syndrome virus | 45 |
two years | 45 |
per day | 45 |
one study | 45 |
clinical manifestations | 45 |
diarrheal disease | 45 |
population density | 45 |
ich regions | 44 |
liberal international | 44 |
important role | 44 |
west africa | 44 |
vaccination program | 44 |
animals will | 44 |
widely used | 44 |
renal failure | 43 |
contaminated food | 43 |
patients receiving | 43 |
first year | 43 |
forced migration | 43 |
growth rate | 43 |
commonly used | 43 |
become infected | 43 |
trade center | 43 |
also known | 43 |
highly pathogenic | 43 |
total number | 43 |
platelet count | 43 |
also may | 43 |
hematopoietic stem | 43 |
common cause | 43 |
adverse effects | 43 |
blood cells | 42 |
old male | 42 |
vaccination coverage | 42 |
european countries | 42 |
significantly higher | 42 |
world bank | 42 |
may become | 42 |
perfringens type | 42 |
south korea | 42 |
clinical presentation | 42 |
blood products | 41 |
lessons learned | 41 |
fatality rate | 41 |
disease surveillance | 41 |
oncology patients | 41 |
economic impact | 41 |
immune system | 41 |
health promotion | 41 |
emerging diseases | 41 |
clinical course | 41 |
mycobacterium tuberculosis | 41 |
allergic rhinitis | 41 |
rabies virus | 40 |
economic growth | 40 |
us department | 40 |
foreign policy | 40 |
commercially available | 40 |
health authorities | 40 |
disease outbreaks | 40 |
antibiotic resistance | 40 |
private sector | 40 |
severe cases | 40 |
antibiotic treatment | 40 |
higher risk | 40 |
newly diagnosed | 40 |
two patients | 40 |
years ago | 40 |
nosocomial infections | 39 |
liver disease | 39 |
less common | 39 |
will need | 39 |
international travel | 39 |
physical examination | 39 |
health status | 39 |
clinical practice | 39 |
medical supplies | 39 |
american academy | 39 |
health risks | 39 |
based precautions | 39 |
clinical studies | 39 |
tick paralysis | 38 |
social security | 38 |
new vaccines | 38 |
health policy | 38 |
life expectancy | 38 |
veterinary public | 38 |
human disease | 38 |
spotted fever | 38 |
research complications | 38 |
high school | 38 |
universal health | 38 |
first time | 38 |
per week | 38 |
viral infections | 38 |
immunocompromised patients | 38 |
bovine tuberculosis | 38 |
rural areas | 38 |
causative agent | 38 |
case report | 38 |
data collection | 37 |
peripheral blood | 37 |
epithelial cells | 37 |
age group | 37 |
eastern europe | 37 |
person transmission | 37 |
health problems | 37 |
may need | 37 |
dairy cattle | 37 |
soft tissue | 37 |
internationally adopted | 37 |
cause disease | 37 |
developing world | 37 |
first years | 37 |
old female | 37 |
five years | 37 |
health outcomes | 37 |
took place | 37 |
natural history | 37 |
year old | 36 |
former soviet | 36 |
borne disease | 36 |
clinical features | 36 |
select agents | 36 |
health professionals | 36 |
tourism industry | 36 |
disease prevention | 36 |
high mortality | 36 |
chronic diseases | 36 |
cases reported | 36 |
also used | 36 |
nationals abroad | 36 |
overall survival | 36 |
salmonella infection | 36 |
signs include | 36 |
age groups | 36 |
emergency management | 36 |
case series | 36 |
wild animals | 36 |
different countries | 36 |
closely related | 35 |
pediatric hematology | 35 |
influenza vaccine | 35 |
southeast asia | 35 |
social media | 35 |
great gatsby | 35 |
science policy | 35 |
economic development | 35 |
kg day | 35 |
antimicrobial agents | 35 |
will require | 35 |
jakob disease | 35 |
pharmaceutical companies | 35 |
fresh produce | 35 |
national security | 35 |
antibiotic use | 35 |
will likely | 35 |
medical records | 35 |
small ruminants | 35 |
mechanical ventilation | 35 |
general population | 35 |
years later | 35 |
animal diseases | 35 |
terrorist attacks | 35 |
infected persons | 34 |
factors associated | 34 |
chagas disease | 34 |
human milk | 34 |
national institutes | 34 |
east asia | 34 |
lower respiratory | 34 |
cold war | 34 |
ich steering | 34 |
significant difference | 34 |
significant differences | 34 |
rocky mountain | 34 |
differential diagnoses | 34 |
hemolytic anemia | 34 |
fatty acids | 34 |
vaccination programs | 34 |
lyme borreliosis | 34 |
local health | 34 |
million doses | 34 |
food safety | 34 |
patients may | 34 |
fluorescent antibody | 34 |
pediatric cancer | 34 |
mass casualty | 34 |
universal access | 33 |
made available | 33 |
three patients | 33 |
cell transplant | 33 |
many years | 33 |
hiv transmission | 33 |
prevent transmission | 33 |
international organizations | 33 |
clostridium perfringens | 33 |
birth cohort | 33 |
disease transmission | 33 |
red cross | 33 |
food allergy | 33 |
international standards | 33 |
cystic fibrosis | 33 |
naturally occurring | 33 |
mass destruction | 33 |
aged years | 33 |
cerebrospinal fluid | 33 |
postexposure prophylaxis | 33 |
industrialized countries | 32 |
cell culture | 32 |
several weeks | 32 |
pediatric population | 32 |
typhoid fever | 32 |
hiv prevention | 32 |
first case | 32 |
drug users | 32 |
lymph node | 32 |
viral hemorrhagic | 32 |
white blood | 32 |
wide variety | 32 |
care delivery | 32 |
high prevalence | 32 |
may require | 32 |
epidemiologic studies | 32 |
tick bites | 32 |
passive immunity | 32 |
preventive measures | 32 |
risk groups | 32 |
infected individuals | 32 |
pharmaceutical regulations | 32 |
airborne transmission | 31 |
rise buildings | 31 |
bacterial infections | 31 |
secondary bacterial | 31 |
respiratory illness | 31 |
eu countries | 31 |
drug use | 31 |
president trump | 31 |
sexually transmitted | 31 |
healthy people | 31 |
tick bite | 31 |
international trade | 31 |
vector control | 31 |
atopic dermatitis | 31 |
birth weight | 31 |
ill patients | 31 |
national dras | 31 |
situation report | 31 |
factor viii | 31 |
respiratory secretions | 31 |
drinking water | 31 |
pediatric patient | 31 |
patients treated | 31 |
best practices | 31 |
health departments | 31 |
antiviral drugs | 31 |
human cases | 31 |
highly contagious | 31 |
health problem | 31 |
cell transplantation | 31 |
relapsing fever | 30 |
erythema migrans | 30 |
health officials | 30 |
ad hoc | 30 |
fire protection | 30 |
may provide | 30 |
stress disorder | 30 |
major cause | 30 |
coronavirus pandemic | 30 |
index case | 30 |
may help | 30 |
also occur | 30 |
cases per | 30 |
preventable diseases | 30 |
pseudomonas aeruginosa | 30 |
older children | 30 |
myeloid leukemia | 30 |
sex workers | 30 |
pharmaceutical products | 30 |
etiologic agent | 30 |
control programs | 30 |
small intestine | 30 |
cancer survivors | 30 |
respiratory symptoms | 30 |
pulmonary edema | 30 |
nursing home | 30 |
psychological trauma | 30 |
immunization schedule | 30 |
otitis media | 30 |
low levels | 30 |
family history | 30 |
solid tumors | 29 |
greater risk | 29 |
contaminated water | 29 |
severe disease | 29 |
international health | 29 |
population health | 29 |
metabolic acidosis | 29 |
prospective studies | 29 |
chronic disease | 29 |
national institute | 29 |
neonatal intensive | 29 |
central america | 29 |
hemorrhagic fevers | 29 |
water supplies | 29 |
healthcare personnel | 29 |
usually occurs | 29 |
risks associated | 29 |
risk management | 29 |
twice daily | 29 |
spongiform encephalopathy | 29 |
care units | 29 |
literature review | 29 |
ixodes scapularis | 29 |
care services | 29 |
several months | 29 |
tract infections | 29 |
urinary tract | 28 |
asthma prevalence | 28 |
controlled trial | 28 |
environmental degradation | 28 |
disease risk | 28 |
wide range | 28 |
global pandemic | 28 |
biological warfare | 28 |
pharmaceutical industry | 28 |
conjugate vaccine | 28 |
every hours | 28 |
hiv status | 28 |
hematology oncology | 28 |
animal products | 28 |
communicable disease | 28 |
bloodstream infections | 28 |
close contact | 28 |
gene expression | 28 |
ich guidelines | 28 |
lassa fever | 28 |
human infection | 28 |
infectious bovine | 28 |
vaccine industry | 28 |
dengue fever | 28 |
nipah virus | 27 |
living systems | 27 |
many people | 27 |
million cases | 27 |
first months | 27 |
watery diarrhea | 27 |
intestinal tract | 27 |
salmonella typhimurium | 27 |
readily available | 27 |
viral hepatitis | 27 |
retrospective review | 27 |
distress syndrome | 27 |
blood samples | 27 |
animal disease | 27 |
resistant enterococci | 27 |
feral cat | 27 |
iron overload | 27 |
germ warfare | 27 |
contact precautions | 27 |
viral diarrhea | 27 |
bacterial pneumonia | 27 |
acute infection | 27 |
data suggest | 27 |
care systems | 27 |
active shooter | 27 |
patients undergoing | 27 |
working groups | 27 |
close contacts | 27 |
one year | 27 |
urban areas | 27 |
acute myeloid | 27 |
healthcare settings | 27 |
bovine spongiform | 27 |
mountain spotted | 27 |
cell count | 27 |
nursing homes | 27 |
emergency department | 27 |
new jersey | 27 |
young adult | 27 |
animal models | 27 |
healthcare providers | 27 |
basic research | 27 |
children younger | 27 |
travel restrictions | 27 |
virus vaccines | 27 |
vulnerable groups | 27 |
bovine viral | 26 |
immune globulin | 26 |
viral infection | 26 |
adult patients | 26 |
national surveillance | 26 |
wild animal | 26 |
haemorrhagic fever | 26 |
costs associated | 26 |
bacillus anthracis | 26 |
veterinary medicine | 26 |
flow cytometry | 26 |
retrospective study | 26 |
international institutions | 26 |
tract infection | 26 |
medical conditions | 26 |
government agencies | 26 |
destination countries | 26 |
vaccine administered | 26 |
states food | 26 |
health risk | 26 |
health department | 26 |
federal agencies | 26 |
among patients | 26 |
treatment plans | 26 |
prevention interventions | 26 |
findings include | 26 |
will become | 26 |
liberal order | 26 |
children aged | 26 |
perceived threat | 26 |
national center | 26 |
significantly lower | 26 |
four patients | 26 |
wildlife interface | 26 |
hodgkin lymphoma | 26 |
one hand | 26 |
long term | 26 |
much less | 26 |
tested positive | 26 |
virus infections | 26 |
acute chest | 25 |
bacterial infection | 25 |
environmental factors | 25 |
health management | 25 |
single dose | 25 |
cancer patients | 25 |
citizens abroad | 25 |
european community | 25 |
began shooting | 25 |
infected children | 25 |
community health | 25 |
displaced persons | 25 |
mg dl | 25 |
acute care | 25 |
health issues | 25 |
eye protection | 25 |
international cooperation | 25 |
puerto rico | 25 |
three times | 25 |
foreign aid | 25 |
emergency response | 25 |
medical treatment | 25 |
months old | 25 |
risk perception | 25 |
chronic lyme | 25 |
rotavirus vaccine | 25 |
posttraumatic stress | 25 |
first step | 25 |
much higher | 25 |
skin test | 25 |
bloody diarrhea | 25 |
patient population | 25 |
universal precautions | 25 |
hospitalized patients | 25 |
environmental contamination | 25 |
median time | 25 |
include fever | 25 |
cholera toxin | 25 |
may vary | 25 |
many different | 25 |
borne infectious | 25 |
significant increase | 25 |
clinical syndromes | 25 |
disease among | 24 |
chest radiograph | 24 |
surveillance systems | 24 |
health program | 24 |
healthcare professionals | 24 |
single market | 24 |
streptococcus pneumoniae | 24 |
prevention strategies | 24 |
drug development | 24 |
white house | 24 |
blood culture | 24 |
transmission occurs | 24 |
case reports | 24 |
immune responses | 24 |
chest syndrome | 24 |
western countries | 24 |
blood safety | 24 |
sustainable development | 24 |
study group | 24 |
every year | 24 |
disease threats | 24 |
bovine rhinotracheitis | 24 |
several days | 24 |
health emergency | 24 |
marrow failure | 24 |
surgeon general | 24 |
european pharmaceutical | 24 |
radiation therapy | 24 |
control group | 24 |
respiratory protection | 24 |
relatively low | 24 |
health agencies | 24 |
high fever | 24 |
emerging pathogens | 24 |
must also | 24 |
primary prevention | 24 |
western europe | 24 |
year period | 24 |
serologic tests | 24 |
case definition | 24 |
many cases | 24 |
first reported | 24 |
temporary protection | 24 |
two cases | 24 |
cancer treatment | 23 |
transfusion transmission | 23 |
global warming | 23 |
supply chain | 23 |
shiga toxin | 23 |
among infants | 23 |
immunosorbent assay | 23 |
north korea | 23 |
medical personnel | 23 |
preventing transmission | 23 |
quality improvement | 23 |
attack rate | 23 |
disease outbreak | 23 |
risk perceptions | 23 |
black disease | 23 |
federal funding | 23 |
oral route | 23 |
york times | 23 |
will occur | 23 |
us population | 23 |
hearing loss | 23 |
clinical outcomes | 23 |
zoonotic pathogens | 23 |
campylobacter enteritis | 23 |
million persons | 23 |
us government | 23 |
allergic disease | 23 |
haemophilus influenzae | 23 |
health disparities | 23 |
will help | 23 |
adverse event | 23 |
past decade | 23 |
prime minister | 23 |
donald trump | 23 |
test results | 23 |
global cooperation | 23 |
pericardial effusion | 23 |
may produce | 23 |
infections may | 23 |
lung disease | 23 |
small number | 23 |
infection occurs | 23 |
infected patients | 23 |
people living | 23 |
exponential growth | 23 |
within weeks | 23 |
associated diarrhea | 23 |
sudden death | 23 |
proactive coping | 23 |
several years | 23 |
contagious ecthyma | 23 |
blood transfusions | 23 |
descriptive infrastructure | 22 |
will often | 22 |
seasonal influenza | 22 |
diagnosed asthma | 22 |
clinically significant | 22 |
saudi arabia | 22 |
also found | 22 |
final report | 22 |
annual report | 22 |
listeria monocytogenes | 22 |
host range | 22 |
primary infection | 22 |
last years | 22 |
medical response | 22 |
new world | 22 |
painted toys | 22 |
nerve agent | 22 |
cat populations | 22 |
pet food | 22 |
socioeconomic status | 22 |
human beings | 22 |
antibody response | 22 |
old children | 22 |
high commissioner | 22 |
radiographic features | 22 |
early warning | 22 |
country chapters | 22 |
drug resistance | 22 |
infection rates | 22 |
definitive diagnosis | 22 |
cell proliferation | 22 |
air traffic | 22 |
microbiology laboratory | 22 |
meningococcal disease | 22 |
labour platforms | 22 |
blood pressure | 22 |
disease virus | 22 |
better understand | 22 |
liver biopsy | 22 |
harmonization initiatives | 22 |
vaccinia virus | 22 |
enteric pathogens | 22 |
host disease | 22 |
trypanosoma cruzi | 22 |
high degree | 22 |
smallpox vaccine | 22 |
time period | 22 |
across countries | 22 |
antibody titers | 22 |
one third | 22 |
labour markets | 22 |
three years | 22 |
skin lesions | 22 |
paraquat poisoning | 22 |
fever virus | 22 |
wild birds | 22 |
herpes simplex | 22 |
immunization program | 22 |
national level | 22 |
tissue culture | 22 |
varicella vaccine | 21 |
compounding pharmacies | 21 |
older persons | 21 |
platelet counts | 21 |
human use | 21 |
currently available | 21 |
nk cells | 21 |
biological attack | 21 |
metastatic disease | 21 |
poor prognosis | 21 |
policy makers | 21 |
older animals | 21 |
diarrhea virus | 21 |
pleural effusions | 21 |
exome sequencing | 21 |
care professionals | 21 |
six months | 21 |
natural disaster | 21 |
weight gain | 21 |
clinical characteristics | 21 |
often associated | 21 |
young animals | 21 |
patients diagnosed | 21 |
personal protection | 21 |
avian flu | 21 |
informed consent | 21 |
practices advisory | 21 |
medical services | 21 |
days later | 21 |
foodborne illness | 21 |
transplant recipients | 21 |
san francisco | 21 |
new technologies | 21 |
disseminated intravascular | 21 |
coverage among | 21 |
within months | 21 |
another study | 21 |
based surveillance | 21 |
better understanding | 21 |
lesions include | 21 |
transmitted diseases | 21 |
economic activities | 21 |
hsct patients | 21 |
infected infants | 21 |
health programs | 21 |
environmental protection | 21 |
vast majority | 21 |
diseases caused | 21 |
two decades | 21 |
beta toxin | 21 |
compounding errors | 21 |
many parts | 21 |
first described | 21 |
months later | 21 |
statistical analysis | 21 |
mental status | 21 |
congenital heart | 21 |
infections among | 21 |
vaccine series | 21 |
weapons convention | 21 |
among persons | 21 |
serologic testing | 21 |
fire alarm | 21 |
may play | 21 |
methyl bromide | 21 |
health security | 21 |
current order | 21 |
linked immunosorbent | 21 |
american association | 21 |
international guidelines | 21 |
technical requirements | 21 |
may appear | 21 |
amblyomma americanum | 20 |
endemic area | 20 |
findings suggest | 20 |
domestic animal | 20 |
salmonella infections | 20 |
preventive services | 20 |
viral load | 20 |
human population | 20 |
enteric disease | 20 |
different types | 20 |
human papillomavirus | 20 |
large animal | 20 |
nucleic acid | 20 |
broad range | 20 |
deaths per | 20 |
patient developed | 20 |
respiratory infection | 20 |
nuclear weapons | 20 |
stool cultures | 20 |
new england | 20 |
high level | 20 |
cause severe | 20 |
patients aged | 20 |
ct scan | 20 |
death toll | 20 |
botulinum toxin | 20 |
molecular epidemiology | 20 |
fever viruses | 20 |
child care | 20 |
animal species | 20 |
early childhood | 20 |
vaccine safety | 20 |
medical management | 20 |
diagnostic tests | 20 |
also associated | 20 |
wilms tumor | 20 |
yersinia enterocolitica | 20 |
among adults | 20 |
cardiovascular disease | 20 |
social support | 20 |
pulmonary disease | 20 |
twentieth century | 20 |
continuing professional | 20 |
death rates | 20 |
clinical symptoms | 20 |
equine encephalitis | 20 |
emerging zoonoses | 20 |
chronic diarrhea | 20 |
air travel | 20 |
healthy adults | 20 |
physical activity | 20 |
neutralizing antibodies | 20 |
infants born | 20 |
member countries | 20 |
surge capacity | 20 |
nerve agents | 20 |
prevalence rates | 20 |
clinical management | 20 |
vesicular stomatitis | 20 |
negative bacilli | 20 |
study period | 20 |
home country | 20 |
one example | 20 |
virus isolation | 20 |
cell death | 20 |
red cell | 20 |
highest risk | 20 |
pneumococcal conjugate | 20 |
barr virus | 20 |
mesenteric lymph | 20 |
vaccine production | 20 |
resistant organisms | 20 |
chronic hepatitis | 20 |
goat kids | 20 |
prevention science | 20 |
per million | 20 |
state university | 20 |
free trade | 20 |
klebsiella pneumoniae | 19 |
severe anemia | 19 |
income inequality | 19 |
cases occur | 19 |
cultural property | 19 |
supreme court | 19 |
inflammatory response | 19 |
two groups | 19 |
virus transmission | 19 |
well documented | 19 |
data collected | 19 |
modified live | 19 |
leading causes | 19 |
significantly increased | 19 |
financial crisis | 19 |
marketing authorization | 19 |
susceptible individuals | 19 |
selective pressure | 19 |
dominican republic | 19 |
pediatric travelers | 19 |
sexual orientation | 19 |
personal hygiene | 19 |
leukemia virus | 19 |
emergency medical | 19 |
wound infections | 19 |
first century | 19 |
bite wounds | 19 |
care setting | 19 |
humanitarian assistance | 19 |
us public | 19 |
may remain | 19 |
directive eec | 19 |
billion per | 19 |
executive order | 19 |
surgical resection | 19 |
sexual exploitation | 19 |
control study | 19 |
central venous | 19 |
diarrheal diseases | 19 |
next generation | 19 |
many patients | 19 |
significant risk | 19 |
scientific community | 19 |
health coverage | 19 |
antiretroviral therapy | 19 |
health workers | 19 |
vascular malformations | 19 |
induction therapy | 19 |
relatively high | 19 |
study conducted | 19 |
older age | 19 |
medical history | 19 |
invasive species | 19 |
passive transfer | 19 |
higher rates | 19 |
one another | 19 |
studies suggest | 19 |
statistical significance | 19 |
encephalitis virus | 19 |
sri lanka | 19 |
survival rates | 19 |
persons aged | 19 |
clinical microbiology | 19 |
affected areas | 19 |
less frequently | 19 |
risk reduction | 19 |
airway obstruction | 19 |
natural infection | 19 |
low cost | 19 |
intestinal mucosa | 19 |
biotic impoverishment | 19 |
examples include | 19 |
armed conflict | 19 |
human granulocytic | 19 |
influenza vaccination | 19 |
shock syndrome | 19 |
general public | 19 |
per patient | 19 |
european parliament | 19 |
whole blood | 19 |
vaccine supply | 19 |
lower lobes | 19 |
previously described | 19 |
marrow transplantation | 19 |
concept paper | 19 |
increasing number | 19 |
prevention recommendations | 19 |
patients without | 19 |
nosocomial infection | 19 |
prevention measures | 19 |
may contribute | 19 |
regulatory authorities | 19 |
sex work | 19 |
inclusion criteria | 19 |
positive blood | 18 |
respiratory diseases | 18 |
whole exome | 18 |
older people | 18 |
home countries | 18 |
may affect | 18 |
ebola outbreak | 18 |
febrile illness | 18 |
clinical diagnosis | 18 |
evidence suggests | 18 |
per hour | 18 |
initial infection | 18 |
hospital medical | 18 |
total population | 18 |
medical record | 18 |
occur within | 18 |
also provides | 18 |
terrorist groups | 18 |
states will | 18 |
times daily | 18 |
will develop | 18 |
may take | 18 |
gene therapy | 18 |
lockdown measures | 18 |
future research | 18 |
cattle fever | 18 |
injection drug | 18 |
key role | 18 |
health infrastructure | 18 |
cough etiquette | 18 |
marrow transplant | 18 |
state health | 18 |
contact tracing | 18 |
potential risk | 18 |
gram negative | 18 |
infection rate | 18 |
health crisis | 18 |
disease spread | 18 |
limited number | 18 |
nonhuman primates | 18 |
confirmed covid | 18 |
opportunistic infections | 18 |
virus causes | 18 |
eu citizens | 18 |
almost always | 18 |
newborn infant | 18 |
iu kg | 18 |
disease progression | 18 |
trump administration | 18 |
american red | 18 |
like illness | 18 |
chest radiography | 18 |
pandemic will | 18 |
treatment options | 18 |
enteroaggregative escherichia | 18 |
body weight | 18 |
protective immunity | 18 |
social science | 18 |
economic models | 18 |
antibiotics may | 18 |
vod sos | 18 |
health threats | 18 |
protective clothing | 18 |
information systems | 18 |
compounding pharmacy | 18 |
virus may | 18 |
training programs | 18 |
blood smears | 18 |
drug regulatory | 18 |
managed care | 18 |
direito penal | 18 |
necrotizing enterocolitis | 18 |
monoclonal antibody | 18 |
long time | 18 |
outsourcing facilities | 18 |
billion people | 18 |
susceptible persons | 18 |
influenzae type | 18 |
frequently associated | 18 |
clinical presentations | 18 |
health information | 18 |
vaccine manufacturers | 18 |
recent study | 18 |
pulmonary tuberculosis | 18 |
early detection | 18 |
previously reported | 18 |
may increase | 18 |
new vaccine | 18 |
highly infectious | 18 |
droplet precautions | 18 |
research topics | 18 |
incidence rates | 18 |
two months | 18 |
several studies | 18 |
younger animals | 18 |
large scale | 18 |
international tourism | 18 |
therapy may | 18 |
fatality rates | 18 |
health impact | 18 |
population growth | 18 |
resistant strains | 18 |
occupational exposure | 18 |
plant species | 18 |
hpv vaccine | 18 |
raccoon rabies | 18 |
hepatocellular carcinoma | 18 |
viral respiratory | 18 |
infection among | 18 |
acute diarrhea | 18 |
generation sequencing | 18 |
personal communication | 18 |
hcv infection | 18 |
immunization coverage | 18 |
contaminated dog | 18 |
action plan | 18 |
second world | 18 |
sending states | 17 |
fecal contamination | 17 |
surveillance data | 17 |
bacterial pathogens | 17 |
severe illness | 17 |
brain injury | 17 |
also cause | 17 |
also developed | 17 |
immunization policy | 17 |
gates foundation | 17 |
human infections | 17 |
cancer diagnosis | 17 |
major public | 17 |
pharmaceutical regulation | 17 |
least two | 17 |
prion diseases | 17 |
intravascular coagulation | 17 |
agent orange | 17 |
also include | 17 |
quality control | 17 |
cancer therapy | 17 |
northeastern united | 17 |
airway responsiveness | 17 |
two different | 17 |
two doses | 17 |
american college | 17 |
supplementary material | 17 |
bacterial meningitis | 17 |
von willebrand | 17 |
old world | 17 |
high dose | 17 |
ewing sarcoma | 17 |
malignant edema | 17 |
acute gastroenteritis | 17 |
fmd outbreak | 17 |
medical attention | 17 |
neonatal diarrhea | 17 |
control efforts | 17 |
acellular pertussis | 17 |
pet ct | 17 |
medical examination | 17 |
anthrax attacks | 17 |
sierra leone | 17 |
respiratory pathogens | 17 |
lung injury | 17 |
pcr assay | 17 |
organ systems | 17 |
higher levels | 17 |
diagnostic testing | 17 |
health sector | 17 |
mutual recognition | 17 |
disease occurs | 17 |
global harmonization | 17 |
airborne precautions | 17 |
highly effective | 17 |
blood supply | 17 |
southwestern united | 17 |
variant creutzfeldt | 17 |
three countries | 17 |
death rate | 17 |
costa rica | 17 |
month period | 17 |
coxiella burnetii | 17 |
cervical cancer | 17 |
new infections | 17 |
life safety | 17 |
respiratory illnesses | 17 |
domestic poultry | 17 |
many areas | 17 |
supportive therapy | 17 |
clinical cases | 17 |
lesions may | 17 |
centralized procedure | 17 |
early stages | 17 |
laboratory workers | 17 |
care centers | 17 |
anthrax spores | 17 |
neutrophil count | 17 |
pilot study | 17 |
states may | 17 |
times higher | 17 |
acute bronchitis | 17 |
may show | 17 |
shortly thereafter | 17 |
five patients | 17 |
substantive infrastructure | 17 |
economic impacts | 17 |
acquired infections | 17 |
help prevent | 17 |
live attenuated | 17 |
prairie dogs | 17 |
economic sanctions | 17 |
mycobacterium bovis | 17 |
logistic regression | 17 |
research team | 17 |
chronic infection | 17 |
renewable energy | 17 |
first cases | 17 |
indirect contact | 17 |
brain tumors | 17 |
social services | 17 |
children living | 17 |
air force | 17 |
approximately one | 17 |
ml kg | 17 |
first hours | 17 |
laboratory findings | 17 |
pathogenic avian | 17 |
chest pain | 17 |
pneumonic plague | 17 |
cell line | 17 |
septic shock | 17 |
developed world | 17 |
provide information | 17 |
less commonly | 17 |
rotavirus infections | 17 |
two weeks | 17 |
disease emergence | 17 |
sulfuryl fluoride | 17 |
body condition | 17 |
national immunization | 17 |
first recognized | 17 |
made disasters | 17 |
reported among | 17 |
premature infants | 17 |
second dose | 17 |
cohort studies | 17 |
nosocomial transmission | 17 |
southern africa | 16 |
early recognition | 16 |
viral diseases | 16 |
diseases may | 16 |
viral disease | 16 |
cancer imaging | 16 |
blood flow | 16 |
western blot | 16 |
enteric infections | 16 |
depressive symptoms | 16 |
health measures | 16 |
francisella tularensis | 16 |
ich process | 16 |
significantly associated | 16 |
asylum seekers | 16 |
prevalence rate | 16 |
business plan | 16 |
economic activity | 16 |
health needs | 16 |
young infants | 16 |
uremic syndrome | 16 |
making process | 16 |
symptoms may | 16 |
animal welfare | 16 |
residual disease | 16 |
also established | 16 |
rise building | 16 |
occupational health | 16 |
hantavirus pulmonary | 16 |
usually associated | 16 |
emergency preparedness | 16 |
vaccine research | 16 |
national academy | 16 |
global fund | 16 |
pulmonary syndrome | 16 |
global response | 16 |
wildlife trade | 16 |
approximately million | 16 |
international conference | 16 |
chronic liver | 16 |
nations international | 16 |
mortality weekly | 16 |
well tolerated | 16 |
respiratory droplets | 16 |
borne relapsing | 16 |
pulmonary function | 16 |
gestational age | 16 |
risk patients | 16 |
disease severity | 16 |
healthcare systems | 16 |
case studies | 16 |
neurologic disease | 16 |
aborted fetuses | 16 |
virulence factors | 16 |
microbial threats | 16 |
workplace violence | 16 |
resistant salmonella | 16 |
natural hazards | 16 |
blood smear | 16 |
medical equipment | 16 |
response efforts | 16 |
health effects | 16 |
epec gastroenteritis | 16 |
severely affected | 16 |
free survival | 16 |
vertical transmission | 16 |
information regarding | 16 |
regulatory framework | 16 |
economic losses | 16 |
amino acid | 16 |
two major | 16 |
intermediate hosts | 16 |
research institute | 16 |
issues related | 16 |
transmissible spongiform | 16 |
th percentile | 16 |
crisis management | 16 |
affected area | 16 |
microscopic examination | 16 |
average age | 16 |
emerging disease | 16 |
often used | 16 |
yersinia pestis | 16 |
pertussis vaccine | 16 |
healthcare system | 16 |
geographic location | 16 |
care provider | 16 |
introduced species | 16 |
active disease | 16 |
polio vaccine | 16 |
social mobility | 16 |
first days | 16 |
cases may | 16 |
inactivated vaccines | 16 |
disease burden | 16 |
outdoor recreation | 16 |
complement fixation | 16 |
common clinical | 16 |
surface antigen | 16 |
traumatic stressors | 16 |
international community | 16 |
lower levels | 16 |
negative bacteria | 16 |
real time | 16 |
electronic medical | 16 |
mediated immunity | 16 |
fungal infections | 16 |
organ transplantation | 16 |
milk replacers | 16 |
first wave | 16 |
may represent | 16 |
gov research | 16 |
among pediatric | 16 |
global economy | 16 |
carrier animals | 16 |
secondary infection | 16 |
copper sulfate | 16 |
patients developed | 16 |
cases occurred | 16 |
borne encephalitis | 16 |
harmonization activities | 16 |
international collaboration | 16 |
virus spread | 16 |
foot rot | 16 |
infective endocarditis | 16 |
topics lyme | 16 |
first world | 16 |
international travelers | 16 |
adult cattle | 16 |
disease characterized | 16 |
vaccination rates | 16 |
hbv infection | 16 |
control strategies | 16 |
hand washing | 16 |
wbc count | 16 |
health emergencies | 16 |
environmental conditions | 16 |
grade fever | 15 |
adverse outcomes | 15 |
vibrio cholerae | 15 |
biological threats | 15 |
human influenza | 15 |
valley fever | 15 |
civil war | 15 |
adverse reactions | 15 |
health assembly | 15 |
washington state | 15 |
blood loss | 15 |
regulatory harmonization | 15 |
far less | 15 |
cause acute | 15 |
particularly important | 15 |
tuberculin skin | 15 |
building codes | 15 |
otherwise healthy | 15 |
sars outbreak | 15 |
outer surface | 15 |
infection prevention | 15 |
diagnoses include | 15 |
pathogen transmission | 15 |
granulocytic ehrlichiosis | 15 |
case study | 15 |
donor screening | 15 |
also important | 15 |
oral rehydration | 15 |
wildlife health | 15 |
low birth | 15 |
specific treatment | 15 |
global public | 15 |
immune status | 15 |
bcg vaccine | 15 |
public policy | 15 |
contagious diseases | 15 |
traffic management | 15 |
old woman | 15 |
median follow | 15 |
respiratory health | 15 |
nutritional status | 15 |
family physicians | 15 |
clinical data | 15 |
first week | 15 |
diarrhea may | 15 |
important cause | 15 |
rift valley | 15 |
agents may | 15 |
pan american | 15 |
infection associated | 15 |
mycoplasma species | 15 |
pharmacy practice | 15 |
black death | 15 |
life threatening | 15 |
common causes | 15 |
may exhibit | 15 |
oncology group | 15 |
estimated million | 15 |
ng ml | 15 |
see also | 15 |
april th | 15 |
immunization programs | 15 |
develop new | 15 |
weekly report | 15 |
risk populations | 15 |
although many | 15 |
control program | 15 |
phylogenetic analysis | 15 |
national interests | 15 |
imaging studies | 15 |
hurricane katrina | 15 |
face masks | 15 |
western united | 15 |
blood product | 15 |
six patients | 15 |
generation cephalosporins | 15 |
criminal laws | 15 |
financial support | 15 |
risk neuroblastoma | 15 |
online survey | 15 |
scd patients | 15 |
extreme weather | 15 |
owned cats | 15 |
recombinant factor | 15 |
research center | 15 |
carrier state | 15 |
rabies vaccine | 15 |
surgical masks | 15 |
bulk tank | 15 |
recommended vaccines | 15 |
bacillary hemoglobinuria | 15 |
protection agency | 15 |
occurs within | 15 |
short period | 15 |
late effects | 15 |
consular services | 15 |
clinical response | 15 |
severe hemophilia | 15 |
nonproductive cough | 15 |
respiratory viruses | 15 |
response strategies | 15 |
million per | 15 |
population groups | 15 |
descriptive statistics | 15 |
smaller ruminants | 15 |
higher incidence | 15 |
phase i | 15 |
effective treatment | 15 |
serious problem | 15 |
potentially infectious | 15 |
last decade | 15 |
common source | 15 |
practice guidelines | 15 |
medical research | 15 |
information sharing | 15 |
large outbreak | 15 |
hiv prevalence | 15 |
occupational safety | 15 |
coronavirus cases | 15 |
hospital care | 15 |
health concern | 15 |
prevention programs | 15 |
gross domestic | 15 |
continuing education | 15 |
analyzed using | 15 |
infection risk | 15 |
transmission risks | 15 |
national fire | 15 |
antibody responses | 15 |
successfully treated | 15 |
living conditions | 15 |
acute renal | 15 |
may reach | 15 |
development goals | 15 |
gold standard | 15 |
two types | 15 |
least months | 15 |
diagnostic methods | 15 |
good manufacturing | 15 |
labour market | 15 |
syndrome coronavirus | 15 |
copper deficiency | 15 |
quality assurance | 15 |
ten years | 15 |
cns tumors | 15 |
cd cells | 15 |
diagnostic laboratory | 15 |
active surveillance | 15 |
sick man | 15 |
fish oil | 15 |
fda approved | 15 |
federal bureau | 15 |
significant impact | 15 |
cell lymphoma | 15 |
also included | 15 |
among young | 15 |
economic model | 15 |
patients will | 15 |
long periods | 15 |
protective effect | 15 |
host country | 15 |
security council | 15 |
fossil fuels | 15 |
retrospective cohort | 15 |
animal rabies | 15 |
economic consequences | 15 |
home health | 15 |
criminal law | 15 |
vaginal discharge | 15 |
pain crisis | 15 |
food security | 15 |
newborn infants | 15 |
management practices | 15 |
endangered species | 15 |
small ruminant | 14 |
exotic species | 14 |
human rotavirus | 14 |
contagious disease | 14 |
may contain | 14 |
infectious complications | 14 |
among adolescents | 14 |
airline industry | 14 |
risk communication | 14 |
pharmaceutical system | 14 |
persistent diarrhea | 14 |
epidemiologic data | 14 |
will die | 14 |
infected animal | 14 |
transmission may | 14 |
raw milk | 14 |
biological attacks | 14 |
body mass | 14 |
patient safety | 14 |
two countries | 14 |
many others | 14 |
organisms may | 14 |
food supply | 14 |
hiv infections | 14 |
common among | 14 |
isaac phase | 14 |
genetically modified | 14 |
zoster virus | 14 |
live virus | 14 |
limited resources | 14 |
acute bacterial | 14 |
bite prevention | 14 |
droplet nuclei | 14 |
directive ec | 14 |
vaccine program | 14 |
caprine arthritis | 14 |
natural resources | 14 |
effective vaccine | 14 |
hospital preparedness | 14 |
additional information | 14 |
war i | 14 |
natural reservoir | 14 |
person spread | 14 |
emergency medicine | 14 |
staff members | 14 |
operating room | 14 |
preventive health | 14 |
disaster preparedness | 14 |
heart failure | 14 |
study demonstrated | 14 |
spongiform encephalopathies | 14 |
disaster risk | 14 |
major role | 14 |
host species | 14 |
liver enzymes | 14 |
tcd screening | 14 |
three major | 14 |
much larger | 14 |
strategic plan | 14 |
health regulations | 14 |
lower risk | 14 |
will take | 14 |
respiratory hygiene | 14 |
adherence rates | 14 |
doses per | 14 |
one health | 14 |
carbon dioxide | 14 |
genetic testing | 14 |
inspection service | 14 |
president obama | 14 |
japanese encephalitis | 14 |
appropriate antibiotic | 14 |
active tuberculosis | 14 |
outdoor workers | 14 |
also reported | 14 |
new information | 14 |
hygiene cough | 14 |
childhood immunization | 14 |
mcar antibodies | 14 |
heart rate | 14 |
several countries | 14 |
vienna convention | 14 |
international airport | 14 |
absolute neutrophil | 14 |
near future | 14 |
new challenges | 14 |
hepatic failure | 14 |
bereaved parents | 14 |
biological products | 14 |
legal framework | 14 |
may predispose | 14 |
health interventions | 14 |
also called | 14 |
fire department | 14 |
human societies | 14 |
liberal values | 14 |
great britain | 14 |
tick vectors | 14 |
political instability | 14 |
us army | 14 |
supply chains | 14 |
internally displaced | 14 |
salmonella enterica | 14 |
health expenditures | 14 |
liver failure | 14 |
human transmission | 14 |
new drug | 14 |
extremely rare | 14 |
care personnel | 14 |
epidemiologic investigation | 14 |
first weeks | 14 |
immune function | 14 |
domestic product | 14 |
differentials include | 14 |
nine patients | 14 |
th epi | 14 |
host cell | 14 |
international organization | 14 |
also increased | 14 |
different levels | 14 |
workers exposed | 14 |
regional harmonization | 14 |
high index | 14 |
tetanus toxoid | 14 |
another important | 14 |
current asthma | 14 |
pediatric intensive | 14 |
serum antibody | 14 |
diagnostic laboratories | 14 |
new mexico | 14 |
protection association | 14 |
third countries | 14 |
patient harm | 14 |
analysis revealed | 14 |
third trimester | 14 |
water supply | 14 |
traditional medicines | 14 |
infant mortality | 14 |
occupational exposures | 14 |
military personnel | 14 |
clinical findings | 14 |
time pcr | 14 |
study reported | 14 |
results suggest | 14 |
state actors | 14 |
organ transplant | 14 |
radioactive material | 14 |
infected cattle | 14 |
symptom onset | 14 |
resistant bacteria | 14 |
canine rabies | 14 |
sustainable finance | 14 |
national vaccine | 14 |
symptoms include | 14 |
way forward | 14 |
mammary gland | 14 |
forced migrants | 14 |
three cases | 14 |
economic cooperation | 14 |
data regarding | 14 |
associated infections | 14 |
well studied | 14 |
ixodes ticks | 14 |
diabetic foot | 14 |
great deal | 14 |
health response | 14 |
important factors | 14 |
infantile diarrhea | 14 |
mucous membrane | 14 |
electron microscopy | 14 |
animal reservoirs | 14 |
early diagnosis | 14 |
induction chemotherapy | 14 |
less severe | 14 |
complete remission | 14 |
throw away | 14 |
first two | 14 |
high rate | 14 |
local transmission | 14 |
nobel prize | 14 |
global trade | 14 |
also identified | 14 |
data analysis | 14 |
research council | 14 |
low risk | 14 |
often fatal | 14 |
salmonella spp | 14 |
found dead | 14 |
previous studies | 14 |
mg ml | 14 |
dengue hemorrhagic | 13 |
individuals may | 13 |
organ failure | 13 |
medical countermeasures | 13 |
johns hopkins | 13 |
cd count | 13 |
host immune | 13 |
artificial insemination | 13 |
will reduce | 13 |
cognitive impairment | 13 |
public awareness | 13 |
shooter incidents | 13 |
rates among | 13 |
study found | 13 |
central line | 13 |
susceptible population | 13 |
pneumococcal disease | 13 |
severe respiratory | 13 |
asymptomatic infection | 13 |
infections associated | 13 |
acute phase | 13 |
widespread use | 13 |
acute lung | 13 |
will remain | 13 |
health concerns | 13 |
see http | 13 |
breeding season | 13 |
significant number | 13 |
international license | 13 |
universal coverage | 13 |
preventive medicine | 13 |
high incidence | 13 |
systemic toxemia | 13 |
significant association | 13 |
cancer care | 13 |
surgical procedures | 13 |
pain control | 13 |
organized crime | 13 |
tick exposure | 13 |
healthy individuals | 13 |
hemolytic uremic | 13 |
emerging zoonotic | 13 |
product recalls | 13 |
local epidemics | 13 |
tobacco use | 13 |
fluid therapy | 13 |
equally important | 13 |
environmental health | 13 |
certain areas | 13 |
ambulatory care | 13 |
significantly reduced | 13 |
adopted child | 13 |
committee meeting | 13 |
states alone | 13 |
compounded medications | 13 |
dublin infection | 13 |
million deaths | 13 |
deaths caused | 13 |
commission proposal | 13 |
gram stain | 13 |
animals culled | 13 |
copy number | 13 |
local governments | 13 |
early stage | 13 |
signifi cant | 13 |
viral haemorrhagic | 13 |
scientific advice | 13 |
including humans | 13 |
many factors | 13 |
european medicines | 13 |
security act | 13 |
national governments | 13 |
per milliliter | 13 |
bluetongue virus | 13 |
large animals | 13 |
new orleans | 13 |
coronavirus outbreak | 13 |
editorial staff | 13 |
virus disease | 13 |
red cells | 13 |
national science | 13 |
high grade | 13 |
south american | 13 |
pharmaceutical interventions | 13 |
hemorrhagic disease | 13 |
significant decrease | 13 |
persistently infected | 13 |
longer term | 13 |
chronic transfusion | 13 |
influenza vaccines | 13 |
cow disease | 13 |
infectious dose | 13 |
diaspora policies | 13 |
nearly billion | 13 |
fusobacterium necrophorum | 13 |
law dictionary | 13 |
will certainly | 13 |
every day | 13 |
avert hospitalizations | 13 |
febrile neutropenia | 13 |
toxoplasma gondii | 13 |
research facility | 13 |
specific ige | 13 |
patient outcomes | 13 |
kidney disease | 13 |
armed forces | 13 |
neonatal rotavirus | 13 |
growing number | 13 |
private insurance | 13 |
melinda gates | 13 |
seek medical | 13 |
forward prevention | 13 |
day course | 13 |
genome sequencing | 13 |
individual countries | 13 |
related deaths | 13 |
term follow | 13 |
communication skills | 13 |
stool specimens | 13 |
may present | 13 |
immigration status | 13 |
sore throat | 13 |
caseous lymphadenitis | 13 |
randomized controlled | 13 |
see section | 13 |
directly related | 13 |
higher education | 13 |
unpasteurized milk | 13 |
national park | 13 |
isolation precautions | 13 |
herpes zoster | 13 |
infectious mononucleosis | 13 |
crucial role | 13 |
health consequences | 13 |
fatal disease | 13 |
medical students | 13 |
vaccine given | 13 |
large part | 13 |
may reveal | 13 |
different species | 13 |
specific antibodies | 13 |
physical therapy | 13 |
human life | 13 |
regulatory requirements | 13 |
infections caused | 13 |
north carolina | 13 |
chinese government | 13 |
exposed persons | 13 |
harmonization initiative | 13 |
platelet aggregation | 13 |
provide additional | 13 |
technical cooperation | 13 |
terrorist attack | 13 |
ds aml | 13 |
new disease | 13 |
related complications | 13 |
within years | 13 |
may experience | 13 |
solid tumor | 13 |
minority groups | 13 |
early treatment | 13 |
longitudinal study | 13 |
time since | 13 |
treatment plan | 13 |
effective control | 13 |
probable cases | 13 |
angeles county | 13 |
health challenges | 13 |
overall health | 13 |
agents include | 13 |
probable case | 13 |
copyright holder | 13 |
international law | 13 |
based study | 13 |
clinical research | 13 |
clinical history | 13 |
active tb | 13 |
special supplement | 13 |
salmonella gastroenteritis | 13 |
nosocomial outbreak | 13 |
environmental sampling | 13 |
environmental challenges | 13 |
high frequency | 13 |
mortality may | 13 |
cutaneous anthrax | 13 |
tyrosine kinase | 13 |
potential threat | 13 |
active ingredient | 13 |
school closures | 13 |
acquired immunodeficiency | 13 |
first month | 13 |
imported malaria | 13 |
common finding | 13 |
policy issues | 13 |
cause serious | 13 |
travel bans | 13 |
hay fever | 13 |
sudden onset | 13 |
tumor cells | 13 |
exposed population | 13 |
diagnostic test | 13 |
bloodborne pathogens | 13 |
dairy products | 13 |
th floor | 13 |
well described | 13 |
mononuclear cells | 13 |
high doses | 13 |
year post | 13 |
side effect | 13 |
autosomal recessive | 13 |
assertiveness demands | 13 |
genetic diversity | 13 |
bloodstream infection | 13 |
antibody levels | 13 |
harmonization process | 13 |
sick men | 13 |
deaths reported | 13 |
final rule | 13 |
home orders | 13 |
mad cow | 13 |
environmental change | 13 |
laboratory confirmation | 13 |
severe diarrhea | 13 |
may last | 13 |
live vaccines | 13 |
pulmonary tb | 13 |
scientific research | 13 |
old girl | 13 |
infectious material | 13 |
previous research | 12 |
patient received | 12 |
line treatment | 12 |
complete blood | 12 |
data set | 12 |
analysis showed | 12 |
product quality | 12 |
bovine respiratory | 12 |
health conditions | 12 |
every months | 12 |
local level | 12 |
people died | 12 |
significant role | 12 |
approval process | 12 |
clinical suspicion | 12 |
venous catheters | 12 |
permanent residents | 12 |
medical education | 12 |
animal studies | 12 |
health education | 12 |
vaccine market | 12 |
weeks later | 12 |
adverse health | 12 |
regional lymphadenopathy | 12 |
tb control | 12 |
passive immunization | 12 |
humoral immunity | 12 |
global influenza | 12 |
current international | 12 |
novel influenza | 12 |
death may | 12 |
guidance documents | 12 |
reported case | 12 |
resident nationals | 12 |
organism may | 12 |
affordable care | 12 |
data show | 12 |
medical professionals | 12 |
may offer | 12 |
intravascular hemolysis | 12 |
maintenance therapy | 12 |
unknown origin | 12 |
may benefit | 12 |
blast injury | 12 |
burkitt lymphoma | 12 |
infections transmitted | 12 |
first trimester | 12 |
western hemisphere | 12 |
primary blast | 12 |
especially important | 12 |
influenza season | 12 |
pandemic started | 12 |
care hospitals | 12 |
hospital settings | 12 |
included patients | 12 |
immigration medical | 12 |
expert committee | 12 |
zoonotic infections | 12 |
pregnant animals | 12 |
life sciences | 12 |
environmental surfaces | 12 |
epidemiological studies | 12 |
cigarette smoking | 12 |
health literacy | 12 |
among others | 12 |
fecal shedding | 12 |
western powers | 12 |
day care | 12 |
four cases | 12 |
patients admitted | 12 |
much smaller | 12 |
chronically infected | 12 |
clinical illness | 12 |
mg day | 12 |
patient transmission | 12 |
wildlife species | 12 |
emergency responders | 12 |
care costs | 12 |
state department | 12 |
serious public | 12 |
three months | 12 |
predictive value | 12 |
ige levels | 12 |
clinical development | 12 |
medical screening | 12 |
infected cells | 12 |
social determinants | 12 |
improve health | 12 |
health crises | 12 |
postmortem findings | 12 |
identifi ed | 12 |
air transport | 12 |
distinct effects | 12 |
granted medrxiv | 12 |
zoonotic viruses | 12 |
economic integration | 12 |
pharmaceutical sector | 12 |
newcastle disease | 12 |
two distinct | 12 |
milk production | 12 |
medicines regulatory | 12 |
cryptosporidium parvum | 12 |
local community | 12 |
smallpox vaccination | 12 |
people will | 12 |
immunodeficiency syndrome | 12 |
serum ferritin | 12 |
southeast asian | 12 |
may involve | 12 |
three regions | 12 |
well understood | 12 |
fetal death | 12 |
surface proteins | 12 |
vaccine use | 12 |
pharmaceutical market | 12 |
diagnosis may | 12 |
fatty acid | 12 |
toxic shock | 12 |
epidemiologically important | 12 |
first three | 12 |
graft failure | 12 |
million children | 12 |
social benefits | 12 |
health protection | 12 |
infection transmission | 12 |
least days | 12 |
antimalarial chemoprophylaxis | 12 |
medical oncologists | 12 |
toxic chemicals | 12 |
combination therapy | 12 |
vaccine products | 12 |
human contact | 12 |
cdc recommends | 12 |
central asia | 12 |
internal organs | 12 |
less effective | 12 |
internal medicine | 12 |
factor ix | 12 |
well known | 12 |
posted may | 12 |
parenteral nutrition | 12 |
version posted | 12 |
months post | 12 |
control precautions | 12 |
nutritional support | 12 |
borne pathogens | 12 |
veterinary services | 12 |
index patient | 12 |
versus host | 12 |
may decrease | 12 |
hospital stay | 12 |
sexually active | 12 |
general assembly | 12 |
sexual partners | 12 |
chlamydia psittaci | 12 |
foreign animal | 12 |
commonly affected | 12 |
will provide | 12 |
committed suicide | 12 |
year follow | 12 |
globin gene | 12 |
food production | 12 |
single agent | 12 |
will increase | 12 |
distancing measures | 12 |
member economies | 12 |
project system | 12 |
one time | 12 |
new infectious | 12 |
screening tests | 12 |
also affected | 12 |
also show | 12 |
large proportion | 12 |
chemical warfare | 12 |
reporting system | 12 |
novyi type | 12 |
recent outbreaks | 12 |
african countries | 12 |
elderly persons | 12 |
oral therapy | 12 |
chronically ill | 12 |
resistant tuberculosis | 12 |
commonly associated | 12 |
health threat | 12 |
wildlife diseases | 12 |
fecal leukocytes | 12 |
bleeding disorder | 12 |
blood components | 12 |
section iii | 12 |
live animal | 12 |
one case | 12 |
least three | 12 |
also provide | 12 |
native species | 12 |
face mask | 12 |
specific recommendations | 12 |
first line | 12 |
essential medicines | 12 |
national research | 12 |
immune reconstitution | 12 |
population mobility | 12 |
author funder | 12 |
graft versus | 12 |
common cold | 12 |
significantly decreased | 12 |
factors influencing | 12 |
resistance among | 12 |
allows us | 12 |
herd management | 12 |
sars coronavirus | 12 |
border restrictions | 12 |
york state | 12 |
occupational asthma | 12 |
tumor necrosis | 12 |
terrorist group | 12 |
antimicrobial use | 12 |
cranial nerve | 12 |
future studies | 12 |
epidemics reveal | 12 |
risk areas | 12 |
across borders | 12 |
childhood vaccines | 12 |
old man | 12 |
local area | 12 |
become available | 12 |
traumatic brain | 12 |
hiv testing | 12 |
total deaths | 12 |
young people | 12 |
last two | 12 |
critical role | 12 |
severe headache | 12 |
countries like | 12 |
may reduce | 12 |
occupational risk | 12 |
cd cell | 12 |
pneumonia may | 12 |
effective vaccines | 12 |
empiric antibiotics | 12 |
public opinion | 12 |
population dynamics | 12 |
phase iii | 12 |
tail docking | 12 |
rotavirus diarrhea | 12 |
developmental delay | 12 |
vaccine may | 12 |
community transmission | 12 |
eligible patients | 12 |
lactic acidosis | 12 |
us food | 12 |
free movement | 12 |
body temperature | 12 |
pharmacy education | 12 |
african americans | 12 |
large quantities | 12 |
care act | 12 |
development assistance | 12 |
acute hepatitis | 12 |
usually asymptomatic | 12 |
immunosuppressed patients | 12 |
countries may | 12 |
many states | 12 |
nongovernmental organizations | 12 |
giving rise | 12 |
prevention specialists | 12 |
strongly associated | 12 |
secondary prevention | 12 |
surveillance efforts | 12 |
taken together | 12 |
days post | 12 |
single case | 12 |
population size | 12 |
response plans | 12 |
vaccine shortages | 12 |
toxin production | 12 |
management systems | 12 |
new era | 12 |
susceptible density | 12 |
patient room | 12 |
chronic obstructive | 12 |
studies using | 12 |
prevention activities | 12 |
within hr | 12 |
packed red | 12 |
gastrointestinal symptoms | 12 |
neurologic signs | 12 |
whenever possible | 12 |
many developing | 12 |
face shield | 12 |
fecal culture | 12 |
seven patients | 12 |
reproductive tract | 12 |
healthcare facilities | 12 |
safety culture | 12 |
food insecurity | 12 |
intestinal epithelial | 12 |
day survival | 12 |
tobacco smoke | 12 |
improve outcomes | 11 |
infected blood | 11 |
health indicators | 11 |
products made | 11 |
approximately months | 11 |
rubella vaccine | 11 |
health community | 11 |
unlawful activity | 11 |
also serve | 11 |
concerns regarding | 11 |
bloody stools | 11 |
rabies control | 11 |
affected countries | 11 |
one must | 11 |
foreign countries | 11 |
defense mechanisms | 11 |
disease course | 11 |
babesia microti | 11 |
make sense | 11 |
positive individuals | 11 |
contaminated feed | 11 |
similar results | 11 |
prevention strategy | 11 |
specific risk | 11 |
hendra virus | 11 |
outpatient setting | 11 |
young ruminants | 11 |
mass media | 11 |
clostridium diflicile | 11 |
pediatric emergency | 11 |
foreign bodies | 11 |
well beyond | 11 |
next decade | 11 |
reported deaths | 11 |
fever ticks | 11 |
cxr findings | 11 |
regulatory agencies | 11 |
infections occur | 11 |
economic benefits | 11 |
ixodid ticks | 11 |
observational studies | 11 |
salmonella isolates | 11 |
long run | 11 |
may serve | 11 |
significantly less | 11 |
red deer | 11 |
coronavirus crisis | 11 |
zoonotic agents | 11 |
humanitarian crises | 11 |
cultural heritage | 11 |
medical community | 11 |
regulatory systems | 11 |
patients experienced | 11 |
cell phone | 11 |
show signs | 11 |
blood counts | 11 |
african rodents | 11 |
systemic disease | 11 |
bacterial contamination | 11 |
important step | 11 |
environmental impact | 11 |
diseases include | 11 |
tank milk | 11 |
health importance | 11 |
difficile infection | 11 |
heat wave | 11 |
small intestines | 11 |
pseudomembranous colitis | 11 |
chemical agents | 11 |
bacteria may | 11 |
aml patients | 11 |
marrow evaluation | 11 |
affected individuals | 11 |
liquid waste | 11 |
adult sheep | 11 |
surveillance program | 11 |
swine influenza | 11 |
threat assessment | 11 |
partial response | 11 |
american health | 11 |
college students | 11 |
among health | 11 |